2.
病理分期为Ⅰ-ⅢA期（根据IASLC提议的第7版TNM分期）数据库中以性别和分期分类的细胞类型分布，N=9 137
| 细支气管肺泡癌 | 腺癌 | 鳞癌 | 大细胞癌 | 腺鳞癌 | 总计 | |
| 注：本表得到版权所有者© 2009 by the International Association for the Study of Lung Cancer复制许可 | ||||||
| 女性 | ||||||
| Ⅰ期 | 183 (16%) | 648 (56%) | 247 (21%) | 61 (5%) | 10 (1%) | 1 149 |
| Ⅱ期 | 59 (8%) | 363 (51%) | 219 (31%) | 64 (9%) | 11 (2%) | 716 |
| Ⅲ期 | 34 (7%) | 270 (57%) | 117 (25%) | 37 (8%) | 18 (4%) | 476 |
| 所有女性 | 276 (12%) | 1 281 (55%) | 583 (25%) | 162 (7%) | 39 (2%) | 2 341 |
| 男性 | ||||||
| Ⅰ期 | 154 (6%) | 892 (35%) | 1 296 (51%) | 175 (7%) | 19 (1%) | 2 536 |
| Ⅱ期 | 59 (2%) | 683 (27%) | 1 572 (61%) | 189 (7%) | 58 (2%) | 2 561 |
| Ⅲ期 | 28 (2%) | 479 (28%) | 1 012 (60%) | 124 (7%) | 56 (3%) | 1 699 |
| 所有男性 | 241 (4%) | 2 054 (30%) | 3 880 (57%) | 488 (7%) | 133 (2%) | 6 796 |
| 女性+男性 | ||||||
| Ⅰ期 | 337 (9%) | 1 540 (42%) | 1 543 (42%) | 236 (6%) | 29 (1%) | 3 685 |
| Ⅱ期 | 118 (4%) | 1 046 (32%) | 1 791 (55%) | 253 (8%) | 69 (2%) | 3 277 |
| Ⅲ期 | 62 (3%) | 749 (34%) | 1 129 (52%) | 161 (7%) | 74 (3%) | 2 175 |
| 所有患者 | 517 (6%) | 3 335 (36%) | 4 463 (49%) | 650 (7%) | 172 (2%) | 9 137 |